Online inquiry

IVTScrip™ mRNA-Human ABRACL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14182MR)

This product GTTS-WK14182MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABRACL protein. This product can be used in Oligodendrocyte progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_021243.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 58527
UniProt ID Q9P1F3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABRACL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14182MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5933MR IVTScrip™ mRNA-Human GCET2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA GCET2
GTTS-WK14837MR IVTScrip™ mRNA-Human alpha-SMA, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA alpha-SMA
GTTS-WK15746MR IVTScrip™ mRNA-Human AMBN, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AMBN
GTTS-WK1653MR IVTScrip™ mRNA-Human MCAM, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA MCAM
GTTS-WK25243MR IVTScrip™ mRNA-Human APPL1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA APPL1
GTTS-WK26227MR IVTScrip™ mRNA-Human ARID5A, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARID5A
GTTS-WK20003MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK18818MR IVTScrip™ mRNA-Human ANKRD32, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD32
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →